Advertisement

Virchows Archiv

, Volume 472, Issue 6, pp 999–1005 | Cite as

Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas

  • Roberta Barroso Cavalcante
  • Cassiano Francisco Weege Nonaka
  • Hellen Bandeira de Pontes Santos
  • Silvia Helena Barem Rabenhorst
  • Leão Pereira Pinto
  • Lélia Batista de Souza
Original Article
  • 181 Downloads

Abstract

β-Catenin exerts multiple functions in several neoplasms, playing a major role in cell signaling and tumor progression. This study analyzed possible CTNNB1 mutations in salivary gland pleomorphic adenomas (PAs) and adenoid cystic carcinomas (ACCs), and determined possible differences in β-catenin immunoexpression in relation to these mutations, as well as histopathological aspects of these tumors. Twenty-four PAs (15 cell-rich and 9 cell-poor tumors) and 24 ACCs (10 tubular, 8 cribriform, and 6 solid tumors) were selected for the analysis of β-catenin distribution and cellular localization. Furthermore, β-catenin expression was evaluated using the H-score scoring system. Mutations in CTNNB1 exon 3 were investigated by the single-strand conformational polymorphism test. Diffuse β-catenin expression was more frequently observed in ACCs compared to PAs (P = 0.008). No significant difference in β-catenin cellular localization was observed between these tumors (P = 0.098). Comparisons between PA and ACC cases revealed a higher median H-score in the latter (P = 0.036). Cell-rich PAs exhibited a trend for higher H-score than cell-poor tumors (P = 0.060), whereas lower H-scores were observed in cribriform ACCs when compared to tubular and solid ACCs (P = 0.042). Mutations in CTNNB1 were observed in 6 PAs and 7 ACCs, with no significant difference in H-scores for β-catenin according to mutation status (P = 0.135). β-Catenin is important in the pathogenesis of salivary gland PAs and ACCs. In addition, CTNNB1 exon 3 mutations do not seem to significantly influence β-catenin cytoplasmic/membranous expression or nuclear translocation in these tumors.

Keywords

β-Catenin Salivary gland neoplasm Mutation Immunohistochemistry Pleomorphic adenoma Adenoid cystic carcinoma 

Notes

Funding

This study was supported by grant number 479935/04-1 from the National Council for Scientific and Technological Development (CNPq).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from each patient after approval by the Institutional Ethics Committee on Research Involving Humans.

References

  1. 1.
    Namboodiripad PC (2014) A review: immunological markers for malignant salivary gland tumors. J Oral Biol Craniofac Res 4:127–134CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    de Ridder M, Balm AJ, Smeele LE, Wouters MW, van Dijk BA (2015) An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010). Cancer Epidemiol 39:14–20CrossRefPubMedGoogle Scholar
  3. 3.
    Wang XD, Meng LJ, Hou TT, Huang SH (2015) Tumours of the salivary glands in northeastern China: a retrospective study of 2508 patients. Br J Oral Maxillofac Surg 53:132–137CrossRefPubMedGoogle Scholar
  4. 4.
    Cavalcante RB, Nonaka CF, Rabenhorst SH, da Costa Miguel MC, Pinto LP, de Souza LB (2017) Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism. Arch Oral Biol 73:48–54CrossRefPubMedGoogle Scholar
  5. 5.
    González-Moles MA, Ruiz-Ávila I, Gil-Montoya JA, Plaza-Campillo J, Scully C (2014) β-Catenin in oral cancer: an update on current knowledge. Oral Oncol 50:818–824CrossRefPubMedGoogle Scholar
  6. 6.
    Psyrri A, Kotoula V, Fountzilas E, Alexopoulou Z, Bobos M, Televantou D, Karayannopoulou G, Krikelis D, Markou K, Karasmanis I, Angouridakis N, Kalogeras KT, Nikolaou A, Fountzilas G (2014) Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer. Oral Oncol 50:298–305CrossRefPubMedGoogle Scholar
  7. 7.
    Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ (2017) Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10:101CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bánkfalvi A, Krassort M, Végh A, Felszeghy E, Piffkó J (2002) Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31(450):7Google Scholar
  9. 9.
    Zhang Q, Meng XK, Wang WX, Zhang RM, Zhang T, Ren JJ (2016) The Wnt/β-catenin signaling pathway mechanism for pancreatic cancer chemoresistance in a three-dimensional cancer microenvironment. Am J Transl Res 8:4490–4498PubMedPubMedCentralGoogle Scholar
  10. 10.
    Schneider S, Thurnher D, Seemann R, Brunner M, Kadletz L, Ghanim B, Aumayr K, Heiduschka G, Lill C (2016) The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival. Eur Arch Otorhinolaryngol 273:1283–1292CrossRefPubMedGoogle Scholar
  11. 11.
    Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM (2013) Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 102:74–83CrossRefPubMedGoogle Scholar
  12. 12.
    Takahara M, Kishibe K, Bandoh N, Nonaka S, Harabuchi Y (2004) P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan. Hum Pathol 35:86–95CrossRefPubMedGoogle Scholar
  13. 13.
    Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G (2001) Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987–996CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Soares AB, de Araújo VC, Juliano PB, Altemani A (2009) Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma. J Oral Pathol Med 38:623–629CrossRefPubMedGoogle Scholar
  15. 15.
    Ellis GL, Auclair PL (2008) Tumors of the salivary glands. AFIP atlas of tumor pathology. ARP Press, Silver Spring MDGoogle Scholar
  16. 16.
    Neves Filho EH, Cordeiro DE, Vieira AP, Rabenhorst SH (2012) TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis. Pathobiology 79:323–328CrossRefPubMedGoogle Scholar
  17. 17.
    McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716–721PubMedGoogle Scholar
  18. 18.
    Daa T, Kashima K, Kaku N, Suzuki M, Yokoyama S (2004) Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Mod Pathol 17:1475–1482CrossRefPubMedGoogle Scholar
  19. 19.
    Hakata Y, Fukui H, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, Imura J, Kawamata H, Imai Y, Fujimori T (2010) Expression of β-catenin and REG Iα in relation to cell proliferative ability in salivary gland tumors. Exp Ther Med 1:437–443CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wang R, Geng N, Zhou Y, Zhang D, Li L, Li J, Ji N, Zhou M, Chen Y, Chen Q (2015) Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma. Biomed Mater Eng 26:S2145–S2153PubMedGoogle Scholar
  21. 21.
    Chandrashekar C, Angadi PV, Krishnapillai R (2011) β-Catenin expression in benign and malignant salivary gland tumors. Int J Surg Pathol 19:433–440CrossRefPubMedGoogle Scholar
  22. 22.
    Zhou CX, Gao Y (2006) Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 16:505–511PubMedGoogle Scholar
  23. 23.
    Furuse C, Cury PR, Altemani A, dos Santos Pinto D Jr, de Araújo NS, de Araújo VC (2006) Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol 14:212–217CrossRefPubMedGoogle Scholar
  24. 24.
    Fonseca I, Fonseca R, Martins C, Soares J (2008) Alteration of beta-catenin localization in salivary pleomorphic adenomas is not related to t(3;8)(p21;q12) and is mainly present in non-epithelial cell types. Histopathology 52:244–247PubMedGoogle Scholar
  25. 25.
    Genelhu MC, Gobbi H, Arantes DC, Cardoso SV, Cassali GD (2007) Immunolocalization of beta-catenin in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Appl Immunohistochem Mol Morphol 15:273–278CrossRefPubMedGoogle Scholar
  26. 26.
    Masuda T, Ishitani T (2017) Context-dependent regulation of the β-catenin transcriptional complex supports diverse functions of Wnt/β-catenin signaling. J Biochem 161:9–17CrossRefPubMedGoogle Scholar
  27. 27.
    Liu Y, Patel L, Mills GB, Lu KH, Sood AK, Ding L, Kucherlapati R, Mardis ER, Levine DA, Shmulevich I, Broaddus RR, Zhang W (2014) Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma. J Natl Cancer Inst 106Google Scholar
  28. 28.
    Jamieson C, Sharma M, Henderson BR (2014) Targeting the β-catenin nuclear transport pathway in cancer. Semin Cancer Biol 27:20–29CrossRefPubMedGoogle Scholar
  29. 29.
    Shiratsuchi H, Nakashima T, Hirakawa N, Toh S, Nakagawa T, Saito T, Tsuneyoshi M, Komune S (2007) Beta-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression. Head Neck 29:577–584CrossRefPubMedGoogle Scholar
  30. 30.
    Jo VY, Sholl LM, Krane JF (2016) Distinctive patterns of CTNNB1 (β-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol 40:1143–1150CrossRefPubMedGoogle Scholar
  31. 31.
    Wilson TC, Ma D, Tilak A, Tesdahl B, Robinson RA (2016) Next-generation sequencing in salivary gland basal cell adenocarcinoma and basal cell adenoma. Head Neck Pathol 10:494–500CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lee YH, Huang WC, Hsieh MS (2017) CTNNB1 mutations in basal cell adenoma of the salivary gland. J Formos Med Assoc.  https://doi.org/10.1016/j.jfma.2017.11.011
  33. 33.
    Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, Mihashi H, Akiba J, Kage M (2011) Nuclear β-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med 40:460–466CrossRefPubMedGoogle Scholar
  34. 34.
    Ferrazzo KL, Neto MM, dos Santos E, dos Santos PD, de Sousa SO (2009) Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. J Oral Pathol Med 38:701–707CrossRefPubMedGoogle Scholar
  35. 35.
    Xu B, Drill E, Ho A, Ho A, Dunn L, Prieto-Granada CN, Chan T, Ganly I, Ghossein R, Katabi N (2017) Predictors of outcome in adenoid cystic carcinoma of salivary glands: a clinicopathologic study with correlation between MYB fusion and protein expression. Am J Surg Pathol 41:1422–1432CrossRefPubMedGoogle Scholar
  36. 36.
    West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT (2011) MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 35:92–99CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Rooney SL, Robinson RA (2017) Immunohistochemical expression of MYB in salivary gland basal cell adenocarcinoma and basal cell adenoma. J Oral Pathol Med 46:798–802CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Roberta Barroso Cavalcante
    • 1
  • Cassiano Francisco Weege Nonaka
    • 2
  • Hellen Bandeira de Pontes Santos
    • 3
  • Silvia Helena Barem Rabenhorst
    • 4
  • Leão Pereira Pinto
    • 3
  • Lélia Batista de Souza
    • 3
  1. 1.Department of Oral PathologyUniversity of FortalezaFortalezaBrazil
  2. 2.Department of DentistryState University of ParaíbaCampina GrandeBrazil
  3. 3.Department of Oral PathologyFederal University of Rio Grande do NorteNatalBrazil
  4. 4.Molecular Genetics Laboratory, Department of Pathology and Forensic MedicineFederal University of CearáFortalezaBrazil

Personalised recommendations